News
Lefamulin found noninferior to moxifloxacin for bacterial pneumonia
October 1, 2019
Oral lefamulin, the first pleuromutilin antibiotic approved for intravenous and oral administration, was noninferior to oral moxifloxacin for inducing an early clinical response in patients with bacterial pneumonia, acording to data from a global multicenter study of 738 individuals.
![1]()
News
Vitamin C infusion falls short for sepsis and ARDS patients
October 1, 2019
Vitamin C failed to improve organ dysfunction, inflammation, or vascular injury in adults with sepsis and ARDS.
![1]()
News
Caution with IVC filters in elderly
September 30, 2019
Are inferior vena cava (IVC) filters in older adults safe for prevention of subsequent pulmonary embolism (PE)?
![1]()
News
CDC reports most vaping lung disease linked to THC-containing cartridges
September 27, 2019
Most vaping cartridges were obtained on the street, from dealers, online, or from friends or social contacts.
![1]()
Article
Short Takes
September 12, 2019
In The Literature's Short Takes
![1]()
News
Consider triple therapy for the management of COPD
September 11, 2019
Does triple therapy for chronic obstructive pulmonary disease (COPD) result in lower rates of COPD exacerbations when compared with dual therapy or monotherapy?
![1]()
News
Older IBD patients are most at risk of postdischarge VTE
September 10, 2019
Readmission for venous thromboembolism in patients with inflammatory bowel diseases most often occurs within 60 days of discharge.
![1]()
News
HFNC 12 L/min on floor cuts down on bronchiolitis ICU transfers
September 2, 2019
Switching from 6 L/min makes a difference.
![1]()
News
FUO, pneumonia often distinguishes influenza from RSV in hospitalized young children
August 22, 2019
LJUBLJANA, SLOVENIA – “These findings open new possibilities for antimicrobial stewardship in these groups of virally infected children.” Dr. Cihan Papan.
![1]()
News
FDA approves Xenleta for community-acquired bacterial pneumonia treatment
August 20, 2019
The approval was based on results from two trials with a total of 1,289 patients.
